Roland Chu

1.0k total citations
30 papers, 716 citations indexed

About

Roland Chu is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Roland Chu has authored 30 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Oncology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Roland Chu's work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Roland Chu is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Roland Chu collaborates with scholars based in United States, China and Pakistan. Roland Chu's co-authors include Fadlo R. Khuri, Erwin G. Van Meir, Dawn E. Post, Jeffrey W. Taub, Holly Edwards, Yubin Ge, Hai Lin, Jun Ma, Guan Wang and Jianyun Zhao and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Roland Chu

28 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Chu United States 11 322 245 202 168 137 30 716
Jutte van der Werff ten Bosch Belgium 15 210 0.7× 123 0.5× 113 0.6× 129 0.8× 89 0.6× 57 671
Keith J. August United States 14 166 0.5× 230 0.9× 408 2.0× 283 1.7× 64 0.5× 50 799
Brigitte Lescoeur France 13 135 0.4× 217 0.9× 141 0.7× 319 1.9× 37 0.3× 28 711
M V Relling United States 9 254 0.8× 307 1.3× 176 0.9× 605 3.6× 52 0.4× 14 877
S.J. Proctor United Kingdom 17 290 0.9× 344 1.4× 333 1.6× 225 1.3× 54 0.4× 44 967
O B Eden United Kingdom 5 280 0.9× 254 1.0× 163 0.8× 459 2.7× 55 0.4× 7 771
Raija Silvennoinen Finland 15 184 0.6× 314 1.3× 211 1.0× 105 0.6× 32 0.2× 38 576
Gladstone Airewele United States 13 223 0.7× 511 2.1× 124 0.6× 254 1.5× 58 0.4× 34 865
Sharon Avery Australia 13 103 0.3× 272 1.1× 161 0.8× 95 0.6× 15 0.1× 42 524
A van der Does-van den Berg Netherlands 21 384 1.2× 580 2.4× 275 1.4× 920 5.5× 48 0.4× 34 1.4k

Countries citing papers authored by Roland Chu

Since Specialization
Citations

This map shows the geographic impact of Roland Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Chu more than expected).

Fields of papers citing papers by Roland Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Chu. The network helps show where Roland Chu may publish in the future.

Co-authorship network of co-authors of Roland Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Chu. A scholar is included among the top collaborators of Roland Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Chu. Roland Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yankelevich, Maxim, Archana Thakur, Shakeel Modak, et al.. (2024). Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for ImmunoTherapy of Cancer. 12(3). e008744–e008744. 12 indexed citations
2.
Yankelevich, Maxim, et al.. (2020). Patterns and correlates of preserved humoral immunity to vaccines in children following allogeneic hematopoietic stem cell transplantation. Pediatric Transplantation. 25(5). e13936–e13936. 2 indexed citations
3.
4.
Rayner, P H, et al.. (2019). Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children. Journal of Pediatric Hematology/Oncology. 41(6). e395–e401. 2 indexed citations
5.
Ravindranath, Yaddanapudi, et al.. (2017). Changes in Bi-ventricular Function After Hematopoietic Stem Cell Transplant as Assessed by Speckle Tracking Echocardiography. Pediatric Cardiology. 39(2). 365–374. 10 indexed citations
6.
Yankelevich, Maxim, et al.. (2017). Small Split Doses of CD34 + Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy. Case Reports in Oncological Medicine. 2017(1). 4184879–4184879.
7.
Ma, Jun, Xinyu Li, Yongwei Su, et al.. (2017). Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells. Scientific Reports. 7(1). 41950–41950. 49 indexed citations
8.
Niu, Xiaojia, Jianyun Zhao, Jun Ma, et al.. (2016). Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells. Clinical Cancer Research. 22(17). 4440–4451. 181 indexed citations
9.
Edwards, Holly, Alan A. Dombkowski, J. Timothy Caldwell, et al.. (2016). Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia. PLoS ONE. 11(8). e0161539–e0161539. 7 indexed citations
10.
Cashen, Katherine, Roland Chu, Justin D. Klein, Peter Rycus, & John M. Costello. (2016). Extracorporeal membrane oxygenation outcomes in children with hemophagocytic lymphohistiocytosis. Perfusion. 32(2). 151–156. 9 indexed citations
11.
Parsons, Helen M., Linda C. Harlan, Susanne Schmidt, et al.. (2015). Who Treats Adolescents and Young Adults with Cancer? A Report from the AYA HOPE Study. Journal of Adolescent and Young Adult Oncology. 4(3). 141–150. 41 indexed citations
12.
Qi, Wenxiu, Wenbo Zhang, Holly Edwards, et al.. (2015). Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo. Cancer Biology & Therapy. 16(12). 1784–1793. 30 indexed citations
13.
Keegan, Theresa H.M., Li Tao, Mindy C. DeRouen, et al.. (2014). Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers?. Journal of Cancer Survivorship. 8(2). 282–292. 77 indexed citations
14.
Cashen, Katherine, Roland Chu, Justin D. Klein, Peter Rycus, & John Costello. (2014). 1041. Critical Care Medicine. 42. A1610–A1611. 1 indexed citations
15.
16.
Bhambhani, Kanta, et al.. (2012). Patterns of Failure in Patients With Primary Intracranial Germinoma Treated With Neoadjuvant Chemotherapy and Radiotherapy. Pediatric Neurology. 47(3). 162–166. 10 indexed citations
17.
Hijiya, Nobuko, Paul S. Gaynon, Elly Barry, et al.. (2009). A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia. 23(12). 2259–2264. 59 indexed citations
18.
Howell, Della L., John Bergsagel, Roland Chu, & Lillian R. Meacham. (2004). Suppression of Hodgkin???s Disease in a Patient With Cushing???s Syndrome. Journal of Pediatric Hematology/Oncology. 26(5). 301–303. 2 indexed citations
19.
Chu, Roland, Dawn E. Post, Fadlo R. Khuri, & Erwin G. Van Meir. (2004). Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer. Clinical Cancer Research. 10(16). 5299–5312. 133 indexed citations
20.
Howard, Lyn, M Oldendorf, & Roland Chu. (1976). Pyridoxine Deficiency: Another Potential Sequel of the Jejunal-Ileal Bypass Procedure. New England Journal of Medicine. 295(13). 733–733. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jutte van der Werff ten Bosch Breakdown of academic impact, for papers by Keith J. August Breakdown of academic impact, for papers by Brigitte Lescoeur Breakdown of academic impact, for papers by M V Relling Breakdown of academic impact, for papers by S.J. Proctor Breakdown of academic impact, for papers by O B Eden Breakdown of academic impact, for papers by Raija Silvennoinen Breakdown of academic impact, for papers by Gladstone Airewele Breakdown of academic impact, for papers by Sharon Avery Breakdown of academic impact, for papers by A van der Does-van den Berg
Rankless by CCL
2026